Comparison

Rash vs Lanthier

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Rash

An educational tool and memory aid for identifying and understanding common childhood eruptive diseases. It offers essential information on care, treatment, and prevention, complemented by visual aids.

Highlights
  • Childhood disease identification
  • Care and treatment information
  • Preventive measures
  • Photos and illustrations
  • Memory aid sheets
  • Multilingual support (English, French, Spanish)
Features
Read full description

This application is an educational tool and memory aid. It has the essential characteristics of the main eruptive childhood diseases: gianotti-crosti, measles, scarlet fever, rubella, fifth disease, roseola, chicken pox disease, hand-foot-mouth disease, meningococcal purpura and Kawasaki disease. It provides useful information on their care, treatment and preventive measures. Features: - Photos - Illustrations - Memory aid sheets - Language: English/French/Spanish

About

Lanthier

Access up-to-date internal medicine information and guidelines quickly and efficiently. This app offers a fast search function, intuitive menus, and direct links to PubMed references. It's designed for physicians, residents, and medical students to use at the bedside.

Highlights
  • Concise bedside information
  • Advanced search function
  • Intuitive menus
  • Direct links to PubMed
  • Personal note-taking
  • Cross-device synchronization
Features
Read full description

“Lanthier” is an internal medicine app based on the seventh edition of the bestselling pocketbook. Completely re-imagined for iOS, this app will allow any physician, resident or medical student to access up-to-date medical information and guidelines quickly and efficiently. Free 7 days trial subscription! “Lanthier Practical Guide to Internal Medicine is a good choice for an app to replace your pocketbook. Beyond providing quality content with references, it has an excellent design that makes it more than just a digitized version of a book. Finding clinically relevant information about a condition is quick and easy.” iMedicalApp.com — FEATURES — • Concise: edited to be useful at the bedside. • Fast: advanced search function, intuitive menus. • Direct link to the references on PubMed and now through Read by QxMD (internet connection required). Build your paper collection using articles selected by Dr Lanthier himself. • MedCalX integration (sold separately): for quick access to the trusted medical calculator. • Take personal notes within the topics and synchronize them across your iOS devices. Perfect for studying for board exams! — TOPICS — Cardiology Dermatology (new) Endocrinology Gastroenterology General Internal Medicine Hematology Infectious Diseases Nephrology Neurology Oncology Pneumology Rheumatology — ABOUT THE LEAD AUTHORS — Dr Luc Lanthier practices General Internal Medicine at the Sherbrooke University Hospital Center and is a Professor of Medicine at the Faculty of Medicine and Health Sciences of the University of Sherbrooke. He is former chair of the French Examination Board for Internal Medicine Exam at the Royal College of Physicians and Surgeons of Canada. Dr Donald Echenberg practices General Internal Medicine at the Sherbrooke University Hospital Center and is an Associate Professor of Medicine at the Faculty of Medicine and Health Sciences of the University of Sherbrooke. He is past president of the Canadian Society of Internal Medicine and is currently Governor of the Quebec Chapter of the American College of Physicians. — DISCLAIMER — This publication (application) is to be used as a guide only. It is intended only for use by licensed medical practitioners and medical students. Every doctor (or prescriber) is responsible for their actions. Therapeutic options presented in this guide reflect current approaches and guidelines in the field of internal medicine. Content has been peer reviewed by leading experts in their respective fields. The authors of Lanthier - Practical Guide to Internal Medicine shall not be liable for any injury and/or damage to persons or property arising from the use of this application. This guide is not meant to replace clinical judgment. It is the responsibility of the licensed prescriber to verify the indications, contraindications and dosage of the medication (and actions) they prescribe. — ABOUT SUBSCRIPTION — Lanthier - Internal Medicine is offered as a subscription service, renewed automatically. Payment will be charged to iTunes Account at confirmation of purchase. The subscription will automatically renew unless auto-renew is turned off at least 24-hours before the end of the current period. The iTunes Account will be charged for renewal within 24-hours prior to the end of the current period. Subscriptions may be managed by the user and auto-renewal may be turned off by going to the application «Settings» section and tapping «Manage Subscriptions» after purchase. For more information on Terms of Use visit https://lanthiermed.com/terms-of-use

Screenshots

Rash4 screens
Lanthier4 screens

Verdict

The call

The clearest difference is price: Lanthier at Free against Rash's $9.99. Lanthier also leads on rating (3.8 vs 1.0) and update cadence (every 2 months vs every 7 months). Rash's advantage is in-app purchases (none vs 2) and review sentiment (88% vs 62%). On ads and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Lanthier is free to download; Rash costs $9.99 up front. Lanthier sells 2 in-app purchases, starting at $19.49 per year. Rash asks for nothing beyond the download.

ReceptionRating · Positive reviews · Number of ratings

Lanthier holds the better App Store score, 3.8 against 1.0. That said, the two scores are not equally well evidenced: Lanthier has 5 ratings behind it against 1, so its average is the more settled of the two. Written reviews complicate that: 88% of Rash's written reviews are positive against 62% of Lanthier's, so the app with the better star average is not the one people write more warmly about.

UpkeepUpdate frequency

Rash ships an update every 7 months, Lanthier every 2 months. The most recent releases landed on September 22, 2026 and September 28, 2026 respectively.

Scorecard8 real differences · 2 level
Rash versus Lanthier: the parameters behind the verdict, then further details
ParameterRashLanthier
Price$9.99Free — better
Rating1.0 (1 ratings)3.8 (5 ratings) — better
Positive reviews87.5% of reviews — better61.9% of reviews
Number of ratings15 — better
Update frequencyEvery 7 monthsEvery 2 months — better
AdsNoNo
In-app purchasesNo — betterYes
MonetizationPaid — betterSubscription
DevicesiPhone, iPad, iPod — betteriPhone, iPad
Requires iOS12.0 — better16.0
Further details — not scored
Size172 MB70 MB
Age rating4+17+
DeveloperBruno GirodiasLes Éditions Formed inc.

Customer experience

Rash

All ratings1 ratings
Positive0.0%
Neutral0.0%
Negative100.0%
Written reviews8 reviews
Positive87.5%
Neutral0.0%
Negative12.5%

Lanthier

All ratings5 ratings
Positive80.0%
Neutral0.0%
Negative20.0%
Written reviews21 reviews
Positive61.9%
Neutral9.5%
Negative28.6%

In-app purchases

None

Rash

No in-app purchases

2 purchases

Lanthier

Subscriptions2
  • Lanthier - current users3 Months trial$19.491 Year
  • Lanthier - new users7 Days trial$19.491 Year

Questions

Is Rash free?
Rash costs $9.99, with no in-app purchases.
Is Lanthier free?
Lanthier is free to download, with in-app purchases available.
Which has better reviews, Rash or Lanthier?
Lanthier is rated higher. Rash averages 1.0 out of 5 from 1 ratings, while Lanthier averages 3.8 from 5 ratings.
Do Rash or Lanthier have ads?
Neither Rash nor Lanthier shows ads.
Which is updated more often, Rash or Lanthier?
Rash ships an update every 7 months, and Lanthier every 2 months. Most recently, Rash was updated on September 22, 2026 and Lanthier on September 28, 2026.

Other comparisons